ATE297917T1 - 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen - Google Patents

4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen

Info

Publication number
ATE297917T1
ATE297917T1 AT99967956T AT99967956T ATE297917T1 AT E297917 T1 ATE297917 T1 AT E297917T1 AT 99967956 T AT99967956 T AT 99967956T AT 99967956 T AT99967956 T AT 99967956T AT E297917 T1 ATE297917 T1 AT E297917T1
Authority
AT
Austria
Prior art keywords
aminomethyl
treatment
gastrointestinal disorders
benzamide
piperidine
Prior art date
Application number
AT99967956T
Other languages
English (en)
Inventor
Jean-Paul Rene Marie A Bosmans
Ann Louise Gabrielle Meulemans
Cleyn Michel Anna Jozef De
Henricus Jacobus Maria Gijsen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE297917T1 publication Critical patent/ATE297917T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99967956T 1998-12-22 1999-12-14 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen ATE297917T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204411 1998-12-22
PCT/EP1999/010064 WO2000037461A1 (en) 1998-12-22 1999-12-14 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ATE297917T1 true ATE297917T1 (de) 2005-07-15

Family

ID=8234539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967956T ATE297917T1 (de) 1998-12-22 1999-12-14 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen

Country Status (34)

Country Link
US (2) US6544997B1 (de)
EP (1) EP1140915B1 (de)
JP (1) JP4615725B2 (de)
KR (1) KR100633680B1 (de)
CN (1) CN1150190C (de)
AR (1) AR024240A1 (de)
AT (1) ATE297917T1 (de)
AU (1) AU770397B2 (de)
BG (1) BG64953B1 (de)
BR (1) BR9916491A (de)
CA (1) CA2355857C (de)
CZ (1) CZ300851B6 (de)
DE (1) DE69925865T2 (de)
DK (1) DK1140915T3 (de)
EA (1) EA003608B1 (de)
EE (1) EE200100335A (de)
ES (1) ES2245131T3 (de)
HK (1) HK1039114B (de)
HR (1) HRP20010445A2 (de)
HU (1) HUP0104838A3 (de)
ID (1) ID28953A (de)
IL (1) IL143858A (de)
MY (1) MY121852A (de)
NO (1) NO321324B1 (de)
NZ (1) NZ512871A (de)
PL (1) PL197409B1 (de)
PT (1) PT1140915E (de)
SI (1) SI1140915T1 (de)
SK (1) SK285829B6 (de)
TR (1) TR200101962T2 (de)
TW (1) TW570920B (de)
UA (1) UA71591C2 (de)
WO (1) WO2000037461A1 (de)
ZA (1) ZA200105135B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485665B2 (en) * 2002-09-12 2009-02-03 Nagase Chemtex Corporation Medicinal composition
JO2478B1 (en) * 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
US7498347B2 (en) 2003-06-19 2009-03-03 Janssen Pharmaceutica, N.V. Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4 antagonists
AU2004254190B2 (en) * 2003-06-19 2010-04-22 Janssen Pharmaceutica N.V. Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
US7652040B2 (en) * 2003-06-19 2010-01-26 Janssen Pharmaceutica N.V. Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
AU2004254193B2 (en) * 2003-06-19 2010-02-18 Janssen Pharmaceutica N.V. 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides
ATE539077T1 (de) * 2003-09-03 2012-01-15 Pfizer Benzimidazolonverbindungen mit agonistischer wirkung am 5-ht4 rezeptor
CA2545092C (en) * 2003-11-24 2010-08-17 Pfizer Inc. Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
BRPI0512046A (pt) 2004-06-15 2008-02-06 Pfizer derivados de ácido benzimidazolona carboxìlico
US20060035890A1 (en) * 2004-08-10 2006-02-16 Amit Banerjee Compounds and methods for the treatment of ubiquitin conjugating disorders
ES2332808T3 (es) * 2004-11-05 2010-02-12 Theravance, Inc. Compuestos agonistas del receptor 5-ht4.
EP1807423B1 (de) * 2004-11-05 2009-05-20 Theravance, Inc. Chinolinon-carboxamid-verbindungen
MX2007007818A (es) * 2004-12-22 2007-09-11 Theravance Inc Compuestos de indazol-carboxamida.
ES2523851T3 (es) * 2005-03-02 2014-12-02 Theravance Biopharma R&D Ip, Llc Compuestos de quinolinona como agonistas de los receptores 5-HT4
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8377968B2 (en) * 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
EP2961403A4 (de) 2013-03-01 2016-11-30 Zalicus Pharmaceuticals Ltd Heterocyclische inhibitoren des natriumkanals
CA3001857A1 (en) * 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
KR20220066252A (ko) 2019-07-11 2022-05-24 프락시스 프리시젼 메디신즈, 인크. T형 칼슘 채널 조절제의 제형 및 이의 사용 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
AU2435092A (en) 1991-08-20 1993-03-16 Smithkline Beecham Plc 5-ht4 receptor antagonists
FI941178L (fi) * 1991-09-12 1994-03-11 Smithkline Beecham Plc 5-HT4-reseptoriantagonisteja
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
NZ246915A (en) * 1992-02-06 1996-05-28 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives, preparation and pharmaceutical compositions thereof
WO1994008994A1 (en) 1992-10-13 1994-04-28 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
GB9219163D0 (en) 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
WO1994010174A1 (en) * 1992-11-05 1994-05-11 Smithkline Beecham Plc Piperidine derivatives as 5-ht4 receptor antagonists
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
CA2237582C (en) * 1996-02-15 2009-04-14 Janssen Pharmaceutica N.V. Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
TW445263B (en) * 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
TW548103B (en) * 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
CA2340952C (en) * 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
DE10217868A1 (de) * 2002-04-22 2003-10-30 Jomed N V Ballon-Katheter

Also Published As

Publication number Publication date
ES2245131T3 (es) 2005-12-16
NO321324B1 (no) 2006-04-24
CN1150190C (zh) 2004-05-19
ZA200105135B (en) 2002-06-21
EA200100710A1 (ru) 2001-12-24
PL197409B1 (pl) 2008-03-31
WO2000037461A1 (en) 2000-06-29
HK1039114A1 (en) 2002-04-12
HUP0104838A2 (hu) 2002-07-29
SK285829B6 (sk) 2007-09-06
ID28953A (id) 2001-07-19
US7205410B2 (en) 2007-04-17
HUP0104838A3 (en) 2003-05-28
AR024240A1 (es) 2002-09-25
JP2002533337A (ja) 2002-10-08
EP1140915A1 (de) 2001-10-10
DK1140915T3 (da) 2005-10-10
MY121852A (en) 2006-02-28
HK1039114B (en) 2005-08-19
CZ20012117A3 (cs) 2001-10-17
NO20012858L (no) 2001-06-08
KR100633680B1 (ko) 2006-10-11
KR20010080293A (ko) 2001-08-22
CA2355857A1 (en) 2000-06-29
SK8592001A3 (en) 2002-02-05
BG105571A (en) 2002-01-31
EA003608B1 (ru) 2003-06-26
BG64953B1 (bg) 2006-10-31
CN1331690A (zh) 2002-01-16
UA71591C2 (en) 2004-12-15
CA2355857C (en) 2008-10-28
EE200100335A (et) 2002-08-15
DE69925865D1 (de) 2005-07-21
EP1140915B1 (de) 2005-06-15
TW570920B (en) 2004-01-11
BR9916491A (pt) 2001-09-04
IL143858A (en) 2005-03-20
TR200101962T2 (tr) 2002-04-22
AU2432800A (en) 2000-07-12
NO20012858D0 (no) 2001-06-08
DE69925865T2 (de) 2006-05-11
JP4615725B2 (ja) 2011-01-19
US6544997B1 (en) 2003-04-08
AU770397B2 (en) 2004-02-19
PL348417A1 (en) 2002-05-20
US20030181456A1 (en) 2003-09-25
IL143858A0 (en) 2002-04-21
NZ512871A (en) 2002-11-26
PT1140915E (pt) 2005-11-30
HRP20010445A2 (en) 2002-06-30
SI1140915T1 (sl) 2005-12-31
CZ300851B6 (cs) 2009-08-26

Similar Documents

Publication Publication Date Title
ATE297917T1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DE69922914D1 (de) Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60300021D1 (de) (S)-4-Amino-5-Chloro-2-Methoxy-N-[1-[1-(2-Tetrahydrofuryl-Carbonyl)-4-Piperidinylmethyl]-4-Piperidinyl]benzamid zur Behandlung von Magen-Darmbewegungskrankheiten
ATE420866T1 (de) 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60019195D1 (de) Behandlung durch Ablation von Knochenmetastasen
ATE250605T1 (de) Piperidin verbindung zur behandlung von psoriasis
DE69839534D1 (de) Sulfonamide zur Behandlung von durch Endothelin vermittelten Störungen
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE50014041D1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE303379T1 (de) 4-(phenyl-piperidin-4-ylidenmethyl)-benzamid- derivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE60104791D1 (de) Cyclobutendion-Derivate zur Behandlung von Artherosclerose
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60133385D1 (de) (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE313528T1 (de) 4-(phenyl(piperidin-4-yl)amino) benzamidderivate und deren verwendung zur behandlung von schmerzen,angst oder gastrointestinalen störungen
ATE300531T1 (de) Isonipecotamide zur behandlung von integrin vermittelten störungen
ATE287400T1 (de) 4-(phenylpiperidin-4-ylidenmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
ATE313529T1 (de) 4-(phenyl(piperidin-4-yl)amino) benzamidderivate und deren verwendung zur behandlung von schmerzen,angst oder gastrointestinalen störungen
DE69918541D1 (de) Verwendung von nmda antagonisten zur behandlung des reizkolons

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140915

Country of ref document: EP

REN Ceased due to non-payment of the annual fee